CRYSTAL MEIER: Open Payments
NPI 1861944183 · FAIRMOUNT CITY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$652 in 37 payments from 17 companies in 2025. Trend: 2023 $825 · 2024 $727 · 2025 $652
Food & beverage: $652
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $83 |
| Novo Nordisk Inc | 5 | $81 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $67 |
| Sumitomo Pharma America, Inc. | 4 | $62 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $49 |
| Phathom Pharmaceuticals, Inc. | 3 | $47 |
| ABBVIE INC. | 2 | $44 |
| Exact Sciences Corporation | 2 | $39 |
| Lilly USA, LLC | 2 | $34 |
| Dexcom, Inc. | 2 | $30 |
Products named: CAPLYTA, Kerendia, GEMTESA, Ozempic, JARDIANCE, VOQUEZNA, Cologuard Collection Kit, MOUNJARO.
Industry payments across PA — which companies pay providers there.
